AgeX Therapeutics AGE

$ 11.3 -10.17%

Quarterly report 2024-Q3
added 11-12-2024

AgeX Therapeutics Balance Sheet 2011-2024 | AGE

Annual Balance Sheet AgeX Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	12.6 M	-	-396 K	-6.71 M	-7.38 M	-	-	-	-	-	-
Long Term Debt	-	-	13.2 M	-	1.53 M	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	428 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	1.53 M	-	-	-	-	-	-	-	-
Total Current Liabilities	5.91 M	10.1 M	8.97 M	5.36 M	3.3 M	-	-	-	-	-	-	-	-
Total Liabilities	6.61 M	20.6 M	15 M	9.32 M	4.82 M	2.44 M	1.31 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	283 K	317 K	180 K	-	-	-	-	-	-
Retained Earnings	-131 M	-116 M	-106 M	-	-86.2 M	-74.1 M	-66.6 M	-	-	-	-	-	-
Total Assets	12 M	3.24 M	3.15 M	3.92 M	7.44 M	10.7 M	9.63 M	-	-	-	-	-	-
Cash and Cash Equivalents	345 K	645 K	584 K	527 K	2.35 M	6.71 M	7.38 M	-	-	-	-	-	-
Book Value	5.36 M	-17.3 M	-11.9 M	-5.4 M	2.62 M	8.23 M	8.32 M	-	-	-	-	-	-
Total Shareholders Equity	5.47 M	-17.2 M	-11.8 M	-5.4 M	2.22 M	7.45 M	8.32 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet AgeX Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	11.2 M	362 K	413 K	1 K	-	-	-	-	15.6 M	-	-	-	-	-	-	-	-	-	-	-	142 K	221 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	21.3 M	27.1 M	15.2 M	4.86 M	3.9 M	34.6 M	32.5 M	20.6 M	17.2 M	15.8 M	14.3 M	15 M	12.4 M	10.8 M	9.26 M	9.32 M	9.32 M	9.32 M	9.32 M	4.82 M	4.82 M	4.82 M	4.82 M	2.44 M	2.44 M	2.44 M	2.44 M	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	275 K	275 K	275 K	275 K	283 K	283 K	283 K	283 K	317 K	317 K	317 K	317 K	180 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-21.8 M	-23.2 M	-5.44 M	-33.2 M	-128 M	-122 M	-119 M	-116 M	-114 M	-111 M	-108 M	-106 M	-104 M	-102 M	-99.2 M	-97.1 M	-97.1 M	-97.1 M	-97.1 M	-86.2 M	-86.2 M	-86.2 M	-86.2 M	-74.1 M	-74.1 M	-74.1 M	-74.1 M	-66.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	7.44 M	10.7 M	10.9 M	8.97 M	12.2 M	12.3 M	12.5 M	3.24 M	2.01 M	2.58 M	2.72 M	3.15 M	2.43 M	2.54 M	3.16 M	3.92 M	3.92 M	3.92 M	3.92 M	7.44 M	7.44 M	7.44 M	7.44 M	10.7 M	10.7 M	10.7 M	10.7 M	9.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	3.18 M	6.06 M	8.71 M	7.62 M	397 K	261 K	280 K	645 K	466 K	702 K	448 K	584 K	731 K	615 K	809 K	527 K	527 K	527 K	527 K	2.35 M	2.35 M	2.35 M	2.35 M	6.71 M	6.71 M	6.71 M	6.71 M	7.38 M	-	-	-	259 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-13.8 M	-16.4 M	-4.31 M	4.11 M	8.31 M	-22.3 M	-20 M	-17.3 M	-15.1 M	-13.3 M	-11.6 M	-11.9 M	-9.98 M	-8.29 M	-6.1 M	-5.4 M	-5.4 M	-5.4 M	-5.4 M	2.62 M	2.62 M	2.62 M	2.62 M	8.23 M	8.23 M	8.23 M	8.23 M	8.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-13.8 M	-16.4 M	-4.31 M	-32.3 M	-33.3 M	-35.3 M	-36.1 M	-17.2 M	-15.1 M	-13.3 M	-11.6 M	-11.8 M	-9.98 M	-8.29 M	-6.06 M	-5.12 M	-5.12 M	-5.12 M	-5.12 M	2.22 M	2.22 M	2.22 M	2.22 M	7.45 M	7.45 M	7.45 M	7.45 M	7.28 M	-	-	-	-22.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency